default author photo

AJM300 Study Group

Toho University Sakura Medical Center, Division of Gastroenterology and Hepatology, Department of Internal Medicine

United States

SCHOLARLY PAPERS

1

DOWNLOADS

121

TOTAL CITATIONS

10

Scholarly Papers (1)

1.

AJM300 (Carotegrast Methyl), an Oral Antagonist of α4-Integrin, as Induction Therapy for Patients with Moderately Active Ulcerative Colitis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase 3 Study

Number of pages: 24 Posted: 06 Dec 2021
Toho University Sakura Medical Center - Department of Internal Medicine, Tokyo Medical and Dental University - Department of Gastroenterology and Hepatology, Ohmori Toshihide gastro-intestinal Clinic - Gastroenterology, Matsushima Clinic Yokohama Japan - Department of gastrointestinal division, Ishida Clinic of IBD and Gastroenterology - IBD and Gastroenterology, National Hospital Organization Hirosaki National Hospital - Department of Gastroenterology and Hematology, Kanke Gastrointestinal Clinic - Gastrointestinal division, Kitasato University - Research and Development Center for New Medical Frontiers, Fukuoka University Chikushi Hospital - Department of Gastroenterology, Hyogo College of Medicine - Center for Inflammatory Bowel Disease, Division of Internal Medicine, National Center of Neurology and Psychiatry, National Center of Neurology and Psychiatry (NCNP) Hospital - Department of Neurology, Komagome Hospital - Department of Neurology, EA Pharma Co., Ltd. - Clinical Development Department, EA Pharma Co., Ltd. - Clinical Development Department, Kitasato University - Center for Advanced IBD Research and Treatment and Toho University Sakura Medical Center, Division of Gastroenterology and Hepatology, Department of Internal Medicine
Downloads 121 (592,433)
Citation 10

Abstract:

Loading...

alpha 4-integrin antagonist, carotegrast methyl, Mayo Clinic scores, induction therapy, randomised controlled study, Ulcerative colitis